<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26871806</article-id>
      <article-id pub-id-type="pmc">4753902</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000002704</article-id>
      <article-id pub-id-type="art-access-id">02704</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>3400</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Multiple Stent Fractures After Everolimus-Eluting Stent Implantation Causing Acute Myocardial Infarction</article-title>
        <subtitle>A Case Report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ji</surname>
            <given-names>Eun Young</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Gyung-Min</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Dae Won</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Tae-Seok</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Chan Joon</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Jung Sun</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Mahn-Won</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Her</surname>
            <given-names>Sung Ho</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Wang.</surname>
            <given-names>Hsueh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Department of Cardiology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</aff>
      <author-notes>
        <corresp>Correspondence: Gyung-Min Park, Department of Cardiology, Daejeon St. Mary's Hospital, The Catholic University of Korea, 64 Daeheung-ro, Joong-gu, Daejeon 301-723, Republic of Korea (e-mail: <email>min8684@hanmail.net</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>6</issue>
      <elocation-id>e2704</elocation-id>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>5</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0">http://creativecommons.org/licenses/by-nc-nd/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e2704.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Stent fracture is an uncommon complication of drug-eluting stent implantation, but it has a clinical significance because of its potential association with adverse cardiac events such as in-stent restenosis, target lesion revascularization, and stent thrombosis. Multiple stent fractures account for a small proportion, but they may lead to more serious complications. Newer generation drug-eluting stents are designed for improved safety and efficacy compared with early generation drug-eluting stents. Multiple stent fractures after newer generation drug-eluting stent implantation are a rare case.</p>
        <p>We report a case of 25-year-old male who presented with acute myocardial infarction caused by multiple stent fractures after everolimus-eluting stents implantation and was treated by balloon angioplasty.</p>
        <p>Physicians should be aware of the possibility of multiple stent fractures even after newer generation drug-eluting stent implantation.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Drug-eluting stents (DES) have become the primary treatment modality for percutaneous coronary intervention owing to the significantly reduced incidence of in-stent restenosis compared to bare metal stents.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> The early generation DES, sirolimus-eluting stent, showed favorable long-term outcomes.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> However, stent fracture has been an important clinical issue of sirolimus-eluting stent because of its potential association with in-stent restenosis, target lesion revascularization, and stent thrombosis.<sup><xref rid="R3" ref-type="bibr">3</xref></sup></p>
      <p>The everolimus-eluting stent is a new generation drug-eluting stent which is based on a thin-strut, cobalt-chromium alloy platform and releases everolimus, a semisynthetic sirolimus analog, from an acrylic and fluoropolymer mixture.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> This new DES has been designed for improved safety and efficacy compared with sirolimus-eluting stent.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Based on these enhanced properties, the everolimus-eluting stent has shown promising clinical outcomes in previous clinical trials.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> However, in this report, we describe a case of 25-year-old male presenting acute myocardial infarction because of multiple stent fractures after everolimus-eluting stents implantation. We obtained written informed consent from the patient for publication of this case report and any accompanying images.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 25-old-year-man with end-stage renal disease secondary to nephrotic syndrome presented with acute chest pain. His initial heart rate was 107&#x200A;beats/min and blood pressure was 100/60&#x200A;mm&#x200A;Hg. An initial electrocardiogram showed ST elevations in leads II, III, and aVF. The initial levels of CK-MB and troponin T were 1.50 and 0.08&#x200A;ng/mL and peaked at 27.30 and 1.47&#x200A;ng/mL. About 10 months ago, he was admitted for unstable angina and successfully treated by deploying 2 everolimus-eluting stents (Xience Xpedition 3.5&#x200A;&#xD7;&#x200A;38&#x200A;mm and 2.75&#x200A;&#xD7;&#x200A;38&#x200A;mm, Abbott Vascular, Santa Clara, CA) in the right coronary artery (Figure <xref ref-type="fig" rid="F1">1</xref>A and B).</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Serial coronary angiograms (A) Initial coronary angiogram revealed total occlusion at mid to distal right coronary artery. (B) The patient was treated by deploying two overlapping everolimus-eluting stents. (C) About ten months later, the patient presented with inferior ST elevation myocardial infarction due to acute thrombotic occlusion at the distal right coronary artery. Angiographic result after balloon angioplasty was acceptable.</p>
        </caption>
        <graphic xlink:href="medi-95-e2704-g001"/>
      </fig>
      <p>Emergency coronary angiography revealed a thrombotic total occlusion at the distal right coronary artery (Figure <xref ref-type="fig" rid="F2">2</xref>A). During the primary percutaneous coronary intervention, a gap was found at the proximal portion of the totally occluded site, which was indicative of a stent fracture (Figure <xref ref-type="fig" rid="F2">2</xref>B and C). We also found multiple stent fractures in other segments in the right coronary artery (Figure <xref ref-type="fig" rid="F2">2</xref>D&#x2013;F). Balloon angioplasty for right coronary artery was performed using Ikazuchi 1.2&#x200A;&#xD7;&#x200A;6&#x200A;mm balloon (Kaneka Medics, Tokyo, Japan), Maverick 1.5&#x200A;&#xD7;&#x200A;15&#x200A;mm balloon (Boston Scientific, Natick, MA), and Ryujin 2.0&#x200A;&#xD7;&#x200A;15&#x200A;mm and 2.5&#x200A;&#xD7;&#x200A;15&#x200A;mm balloons (Terumo, Tokyo, Japan) (Figure <xref ref-type="fig" rid="F1">1</xref>C). The patient was discharged in stable condition.</p>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Images of multiple stent fractures after everolimus-eluting stent implantation. (A) The angiogram revealed a thrombotic total occlusion at the distal segment of right coronary artery. (B) Fluoroscopic imaging shows multiple fractures (arrows) of the implanted everolimus-eluting stents. (C&#x2013;F) Fluoroscopic images obtained using a stent enhancement tool (CLEARstent, Siemens Healthcare, Forchheim, Germany) also demonstrated the multiple stent fractures.</p>
        </caption>
        <graphic xlink:href="medi-95-e2704-g002"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The incidence of stent fracture after DES implantation has been reported up to 8% in clinical studies.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> Stent fracture after DES implantation is an infrequent but potentially serious complication because of its association with higher cardiac event rates.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> The mechanisms of stent fracture have not yet been completely understood. However, several predisposing risk factors for stent fracture have been suggested.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> Anatomic risk factors are tortuous vessels, right coronary artery, and long lesions. Stent-related risk factors are longer stents and sirolimus-eluting stent implantation. Procedural risk factors are balloon overexpansion and overlapping stents.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> In our case, the implantation of longer and overlapping stents at right coronary artery might have contributed to stent fractures.</p>
      <p>Most cases of multiple stent fractures after DES implantation were reported in sirolimus-eluting stent implantation.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> The sirolimus-eluting stent has a relatively thick, rigid, and closed-cell structure with less flexibility and conformability and be more prone to fracture.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> On the contrary, the everolimus-eluting stent has a thin-strut, open-cell design, and cobalt-chromium platform with high flexibility and conformability, which is expected to have potential advantages over sirolimus-eluting stent.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> However, in a recent study, stent fracture after everolimus-eluting stent implantation was observed in 2.9% of lesions and was associated with a higher rate of myocardial infarction, target lesion revascularization, and stent thrombosis.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Furthermore, the present case showed that multiple stent fractures could occur even after new generation everolimus-eluting stent implantation and be associated with unfavorable cardiac events. Therefore, physicians should be aware that various contributing factors mentioned above for the occurrence of stent fracture and multiple stent fractures could be possible even after new generation DESs implantation.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>CONCLUSION</title>
      <p>Multiple stent fractures are rare complication after newer generation DES implantation. However, they may be associated with more serious cardiac events. Therefore, we should pay special attention to the possibility of multiple stent fractures even after newer generation DES implantation.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors have no funding and conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morice</surname><given-names>MC</given-names></name><name><surname>Serruys</surname><given-names>PW</given-names></name><name><surname>Sousa</surname><given-names>JE</given-names></name><etal/></person-group>
<article-title>A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization</article-title>. <source><italic>N Engl J Med</italic></source>
<year>2002</year>; <volume>346</volume>:<fpage>1773</fpage>&#x2013;<lpage>1780</lpage>.<pub-id pub-id-type="pmid">12050336</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morice</surname><given-names>MC</given-names></name><name><surname>Serruys</surname><given-names>PW</given-names></name><name><surname>Barragan</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial</article-title>. <source><italic>J Am Coll Cardiol</italic></source>
<year>2007</year>; <volume>50</volume>:<fpage>1299</fpage>&#x2013;<lpage>1304</lpage>.<pub-id pub-id-type="pmid">17903626</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarty</surname><given-names>T</given-names></name><name><surname>White</surname><given-names>AJ</given-names></name><name><surname>Buch</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Meta-analysis of incidence, clinical characteristics and implications of stent fracture</article-title>. <source><italic>Am J Cardiol</italic></source>
<year>2010</year>; <volume>106</volume>:<fpage>1075</fpage>&#x2013;<lpage>1080</lpage>.<pub-id pub-id-type="pmid">20920641</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>S</given-names></name><name><surname>Serruys</surname><given-names>PW</given-names></name></person-group>
<article-title>Coronary stents: current status</article-title>. <source><italic>J Am Coll Cardiol</italic></source>
<year>2010</year>; <volume>56</volume>:<fpage>S1</fpage>&#x2013;<lpage>S42</lpage>.<pub-id pub-id-type="pmid">20797502</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuramitsu</surname><given-names>S</given-names></name><name><surname>Iwabuchi</surname><given-names>M</given-names></name><name><surname>Haraguchi</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation</article-title>. <source><italic>Circ Cardiovasc Interv</italic></source>
<year>2012</year>; <volume>5</volume>:<fpage>663</fpage>&#x2013;<lpage>671</lpage>.<pub-id pub-id-type="pmid">23011266</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>WS</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Seung</surname><given-names>KB</given-names></name><etal/></person-group>
<article-title>The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation</article-title>. <source><italic>Int J Cardiol</italic></source>
<year>2008</year>; <volume>125</volume>:<fpage>325</fpage>&#x2013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">17434616</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umeda</surname><given-names>H</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Misumida</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes</article-title>. <source><italic>Circ Cardiovasc Interv</italic></source>
<year>2011</year>; <volume>4</volume>:<fpage>349</fpage>&#x2013;<lpage>354</lpage>.<pub-id pub-id-type="pmid">21813403</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alqarqaz</surname><given-names>M</given-names></name><name><surname>Albashaireh</surname><given-names>D</given-names></name><name><surname>Guerrero</surname><given-names>M</given-names></name></person-group>
<article-title>Multiple and recurrent coronary stent fractures</article-title>. <source><italic>J Invasive Cardiol</italic></source>
<year>2014</year>; <volume>26</volume>:<fpage>E7</fpage>&#x2013;<lpage>E12</lpage>.<pub-id pub-id-type="pmid">24402813</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
